FDA clears orphan drug backlog
Law firm DLA Piper has hired James Czaban as a partner in the firm’s government affairs practice and chair of the firm’s US Food and Drug Administration group in Washington, DC.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
James Czaban, lawyer moves, US Food and Drug Administration, DLA Piper, Benjamin Boyd, licensing, due diligence, compliance, Wiley Rein, FDA